Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results
Ruanne V. Barnabas(Harvard University), Pius O. Atonga(Kenya Medical Research Institute), Charlene Biwott(Kenya Medical Research Institute), Diane G. Kanjilal(Massachusetts General Hospital), Denise A. Galloway(Fred Hutch Cancer Center), Amra Hercinovic(Jaeb Center for Health Research), Susan Morrison, Priya R. Prabhu(Fred Hutch Cancer Center), Reena Gulati(Jawaharlal Institute of Post Graduate Medical Education and Research), Elizabeth A. Bukusi(University of California, San Francisco), R. Scott McClelland(University of Nairobi), Jody Carter(Fred Hutch Cancer Center), Nelly Mugo(University of Washington), Maricianah Onono(Kenya Medical Research Institute), Daniel Pacella(Massachusetts General Hospital), Robin A.J. Smith(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Imelda Wakhungu(Kenya Medical Research Institute), Lisa Ondrejcek, G.W. Robertson, Angela Williams(MSD (UK) Limited (United Kingdom)), Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cynthia Akinyi(Kenya Medical Research Institute), Kate B. Heller(University of Washington), Syovata Kimanthi(Kenya Medical Research Institute), Torin Schaafsma(University of Washington), Krissa Gunderson, Connie Celum(University of Washington), Rachel L. Winer(University of Washington), Elizabeth R. Brown(Fred Hutch Cancer Center), Sara Vernam(Gates Foundation), Abdul Rawuf Yousufzay(Gates Foundation), Stephen O. Abiero(Kenya Medical Research Institute), Maqline A. Achola(Kenya Medical Research Institute), Meldah O. Adipo(Kenya Medical Research Institute), Katherine L. Amukonyi(Kenya Medical Research Institute), Teresia O. Akinyi(Kenya Medical Research Institute), Penina N. Amboka(Kenya Medical Research Institute), Karl D. Arum(Kenya Medical Research Institute), Veronica O. Atogo(Kenya Medical Research Institute), M. Wright(Kenya Medical Research Institute), Stephen Cherne, Betty Njoroge(Kenya Medical Research Institute), Leeya F. Pinder(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elena A. Rechkina(University of Washington), Peter Dull(Gates Foundation)
Cited by 91
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection
|New England Journal of Medicine|1992|952
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891